CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Current assets
Cash and cash equivalents	$ 437	$ 698
Other current assets	47	131
Total current assets	484	829
Patent license rights, net	274	353
Furniture and equipment, net	0	0
Total assets	758	1,182
Current liabilities
Accounts payable	393	249
Other accrued liabilities	80	55
Convertible Promissary Notes Payable	1,000	1,000
Total current liabilities	1,473	1,304
Capstone Therapeutics Corp. Stockholders' Equity
Common Stock $.0005 par value; 150,000,000 shares authorized; 40,885,411 shares outstanding June 30, 2017 and December 31, 2016 - See Note F	20	20
Additional paid-in capital	189,477	189,477
Accumulated deficit	(190,212)	(189,619)
Total Capstone Therapeutics Corp. stockholders' equity (deficit)	(715)	(122)
Noncontrolling interest	0	0
Total equity	(715)	(122)
Total liabilities and equity	$ 758	$ 1,182

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Name:	us-gaap_AccountsPayableCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).